col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: National Center for Biotechnology

14 Results       Page 1

 [1] 
  original article Journal Date Title Authors Max. 6 Authors
1 [GO] Eurasian Journal of Applied Biotechnology 2024―Oct―29 INFLUENCE OF PHYSICOCHEMICAL FACTORS ON THE SARS-COV-2 STRAIN ISOLATED FROM A DOG S.O. Sadikaliyeva, E.Zh. Kalimolda, Zh.S. Abay, Ye.A. Shayakhmetov, S.U. Moldagulova, K.A. Shorayeva, K.K. Jekebekov, A.D. Omurtay, A.T. Zhunushov, N.S. Kozhabergenov, B.A. Yespembetov, M.M. Kassenov, A.S. Nurpeisova
2 [GO] Eurasian Journal of Applied Biotechnology 2024―Sep―18 SARS-COV-2 CORONAVIRUS ANTIGENS MODULATE THE ACTIVITY OF HUMAN T-REGULATORY CELLS S.A. Kan, A.V. Lushova, N. Abdolla, R. Tleulieva, Y.V. Perfilyeva, Y.O. Ostapchuk
3 [GO] Eurasian Journal of Applied Biotechnology 2024―Sep―18 ПРИМЕНЕНИЕ MALDI-TOF-MS И МАШИННОГО ОБУЧЕНИЯ ДЛЯ SARS-COV-2 И ДРУГИХ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ И.А. Кадырова, А.А. Султанбекова
4 [GO] Eurasian Journal of Applied Biotechnology 2024―Sep―18 THE RECOMBINANT BACTERIA LACTOCOCCUS LACTIS EXPRESSING SARS-COV-2 SPIKE PROTEIN OR ITS RECEPTOR-BINDING DOMAIN ELICITS AN IMMUNE RESPONSE FOLLOWING ORAL IMMUNISATION OF RATS O.V. Evdokimova, A.E. Akhremchuk, L.N. Valentovich, O.E. Soboleva, S.V. Gubkin
5 [GO] Eurasian Journal of Applied Biotechnology 2024―Jul―05 Targeted in vitro- confirmation of the antiviral activity of Tenvir (Tenofovir) drug against the SARS-COV-2 virus variant B. in Kazakhstan and identifying NSP12 in the viral genome S. Khaidarov, Y. Burashev, N. Kozhabergenov, B. Usserbayev, A. Melisbek, M. Shirinbekov, A. Moldakaryzova, A. Beisenova, A. Mustafaeva, A. Kydyrbaeva
6 [GO] Eurasian Journal of Applied Biotechnology 2024―Apr―04 SUPPRESSOR CELLS (MDSC) REGULATE THE T-CELL RESPONSE IN OLD MICE IMMUNIZED WITH THE WHOLE-VIRION SARS-CoV-2 VACCINE Y.V. Perfilyeva, N. Abdolla, A. Kali, R. Tleulieva, D. Aben, Y. Abdusattarova, A. Lushova, Ye. Ostapchuk, B. Karalnik, N. Belyaev
7 [GO] Eurasian Journal of Applied Biotechnology 2023―Dec―28 STANDARTIZATION OF IMMUNOGENICITY OF INACTIVATED VACCINE QAZVAC AGAINST CORONAVIRUS INFECTION COVID-19 FROM AN EPIDEMIOLOGICALLY RELEVANT STRAIN B.Sh. Myrzakhmetova, G.A. Zhapparova, K.B. Bissenbayeva, A.S. Toytanova, M.S. Tuyskanova, G.D. Nakhanova, S.Sh. Nurabayev, K.D. Zhugunissov, L.B. Kutumbetov
8 [GO] Eurasian Journal of Applied Biotechnology 2023―Oct―16 CO-INFECTION WITH COVID-19 AND GENETIC DIVERSITY OF SARS-COV-2 IN CHILDREN D. Kamalova, M. Makibayeva, A. Amirgazin, S. Abdrakhmanova, I. Sytnik, A. Tuleubaeva, E Ramankulov, A. Shevtsov
9 [GO] Eurasian Journal of Applied Biotechnology 2023―Apr―13 POSSIBILITIES OF USING MEDICINES AND BIOLOGICALLY ACTIVE SUBSTANCES AS CORRECTIVES FOR THE FORMATION OF PULMONARY FIBROSIS DURING SARS-COV-2 INFECTION AND IN THE POST-COVID PERIOD Z.T. Shulgau, Y.K. Kamyshanskiy, A.Y. Gulyayev
10 [GO] Eurasian Journal of Applied Biotechnology 2023―Apr―13 BIOLOGICAL FEATURES OF THE SARS-COV-2 VIRUS FROM DOMESTIC ANIMALS IN THE TERRITORY OF THE RK S.O. Sadikalieva, E.A. Shayakhmetov, A.S. Nurpeisova, K.A. Shoraуeva, Zh.S. Abay, A.D. Omurtaу, S.K. Kopeev, A.K. Nakhanov, A.A. Terebay, B.Sh. Myrzakhmetova, N.S. Kozhabergenov, Ye.O. Abduraimov
11 [GO] Eurasian Journal of Applied Biotechnology 2022―Sep―16 INHIBITORY ACTIVITY OF ARTEMISIA ANNUA L. EXTRACTS AGAINST SARS-COV-2 CORONAVIRUS M. Zhurinov, A. Miftakhova, A. Shustov, V. Keyer, E. Solodova
12 [GO] Eurasian Journal of Applied Biotechnology 2022―Sep―16 THE PLANT ARTEMISIA ANNUA (“SWEET WORMWOOD”) KAZAKHSTAN’S SOURSE OF BIOACTIVE COMPOUNDS POTENTIALLY CURE THE SARS-CoV-2 INFECTION A. Maftakhova, L. Syzdykova, V. Keer, A. Shustov, M. Zhurinov
13 [GO] Eurasian Journal of Applied Biotechnology 2022―Jul―09 NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS G.M. Zauatbayeva, L.R. Syzdykova, V.V. Keyer, A.V. Shustov, A.Z. Abilmagzhanov, M.Zh. Zhurynov
14 [GO] Eurasian Journal of Applied Biotechnology 2022―Jan―12 CRISPR/CAS12A-BASED DIAGNOSTICS FOR COVID-19 A. Kabylbayeva, K. Zharylgassynova, A. Abilova, M. Amanzholova, S. Abeldenov
 [1] 

14 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec